Recently, the results of the international proficiency testing event, RELA 2024, organized by the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) and hosted by the German Society for Clinical Chemistry and Laboratory Medicine (DGKL), were announced. BIOELAB passed 9 IFCC-RELA projects.
The RELA program provides a platform for medical reference laboratories worldwide to demonstrate their reference measurement capabilities, and is recognized as the highest level of quality assessment in the field of clinical chemistry and laboratory medicine. It is regarded as the golden standard for measuring the technical level of reference laboratories.This achievement means that BIOELAB's testing systems' measurement results can be traced back to international standards, ensuring the accuracy of clinical test results.
The nine IFCC-RELA projects passed by BIOELAB in 2024 are as follows:
Quality First, Standards Traceable. Over many years, BIOELAB has independently developed more than 80 biochemical reagents covering liver function, kidney function, cardiovascular, blood sugar, blood lipids, and more. These reagents, combined with AS series fully automatic chemistry analyzers, calibration products,quality control products, and testing procedures,can form a complete traceable system. BIOELAB has participated in RELA certification multiple times, and the excellent performance of our reagents brings accurate and stable test results.
In the future, BIOELAB will continue to promote the standardization, regulation and harmonization of testing, fostering global recognition of test results for more testing projects. Our company will deliver qualified and reliable reagent products to customers, contributing to human health!
